![Andrew James McLean](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Andrew James McLean
Director/Board Member at
Vaccitech (UK) Ltd.
Profile
Andrew James McLean is currently a Non-Executive Director at Vaccitech (UK) Ltd. and a Director at Theolytics Ltd. He was previously a Director at Argonaut Therapeutics Ltd. and a Director at Osler Diagnostics Ltd. from 2016 to 2019.
Andrew James McLean active positions
| Companies | Position | Start |
|---|---|---|
Vaccitech (UK) Ltd.
 Vaccitech (UK) Ltd. BiotechnologyHealth Technology Engages in research and experimental development on biotechnology | Director/Board Member | - |
Theolytics Ltd.
 Theolytics Ltd. BiotechnologyHealth Technology Engages in research and experimental development on biotechnology | Director/Board Member | - |
Former positions of Andrew James McLean
| Companies | Position | End |
|---|---|---|
Osler Diagnostics Ltd.
 Osler Diagnostics Ltd. BiotechnologyHealth Technology Engages in research and development in biotechnology | Director/Board Member | 31/12/2019 |
Argonaut Therapeutics Ltd.
 Argonaut Therapeutics Ltd. BiotechnologyHealth Technology Develops epigenetically-acting drugs which target abnormal arginine methylation in cancer | Director/Board Member | 09/10/2019 |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
4
1st degree connections
4
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
Vaccitech (UK) Ltd.
Vaccitech (UK) Ltd. BiotechnologyHealth Technology Engages in research and experimental development on biotechnology | Health Technology |
Theolytics Ltd.
Theolytics Ltd. BiotechnologyHealth Technology Engages in research and experimental development on biotechnology | Health Technology |
Argonaut Therapeutics Ltd.
Argonaut Therapeutics Ltd. BiotechnologyHealth Technology Develops epigenetically-acting drugs which target abnormal arginine methylation in cancer | Health Technology |
Osler Diagnostics Ltd.
Osler Diagnostics Ltd. BiotechnologyHealth Technology Engages in research and development in biotechnology | Health Technology |
- Stock Market
- Insiders
- Andrew James McLean
